Whitepaper: Prioritising innovation to get ahead of the market
Posted: 3 February 2022 | Merck | No comments yet
This whitepaper explores the conflict that exists between necessary administration tasks and innovation, demonstrating how digitalisation can help.
Administrative tasks related to inventory management are critical to a properly functioning lab, but what if they are hampering scientific innovation?
This whitepaper explores these questions and highlights the tangible benefits of a robust, automated and integrated laboratory system for inventory, safety and compliance.
LANEXO™ System Benefits:
- Improves laboratory productivity: Reduce time spent on inventory management by tracking stock levels and monitoring expiration dates.
- Supports safety & compliance: Reduce compliance & safety risks by automating traceability of reagent documentation and storage compliance check.
- Facilitates quality & data management: Reduce errors with easy specification and identity checks along experimental workflows.
Related content from this organisation
- Moderna-Merck & Co cancer vaccine with Keytruda shows late-stage promise
- Raman-based PAT tool could advance continuous vaccine manufacturing
- Merck acquires JSR Life Sciences chromatography business
- MSD acquisition to accelerate first-in-class COPD drug
- Next drug patent cliff to challenge Big Pharma strategy
Related topics
Analytical techniques, Biopharmaceuticals, Drug Delivery Systems, Formulation, QA/QC, Regulation & Legislation, Research & Development (R&D)








